OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc under contract SPE2DP26F6560 for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, as part of a delivery order under the parent contract SPE2DX25D9900. The award was finalized on June 15, 2026, and the total contract value is detailed in the official award documentation. This procurement is executed under federal procurement authority with no specific set-aside designation and is managed by the Department of Defense. The performance location and point of contact details are not specified in the record, and the contract was posted on the DIBBS system on July 21, 2026, through the official award notice portal.
General Info
Agency
Contract Value
$254NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
